BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Branquinho RT, Roy J, Farah C, Garcia GM, Aimond F, Le Guennec JY, Saude-Guimarães DA, Grabe-Guimaraes A, Mosqueira VC, de Lana M, Richard S. Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide. Sci Rep 2017;7:44998. [PMID: 28349937 DOI: 10.1038/srep44998] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Spósito PÁ, Mazzeti AL, de Oliveira Faria C, Urbina JA, Pound-Lana G, Bahia MT, Mosqueira VF. Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity. Int J Nanomedicine 2017;12:3785-99. [PMID: 28553114 DOI: 10.2147/IJN.S133708] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Lages EB, Fernandes RS, Andrade MMS, Paiyabhroma N, de Oliveira RB, Fernandes C, Cassali GD, Sicard P, Richard S, Branco de Barros AL, Ferreira LAM. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects. Biomed Pharmacother 2021;144:112373. [PMID: 34794238 DOI: 10.1016/j.biopha.2021.112373] [Reference Citation Analysis]
3 Trindade IC, Pound-lana G, Pereira DGS, de Oliveira LAM, Andrade MS, Vilela JMC, Postacchini BB, Mosqueira VCF. Mechanisms of interaction of biodegradable polyester nanocapsules with non-phagocytic cells. European Journal of Pharmaceutical Sciences 2018;124:89-104. [DOI: 10.1016/j.ejps.2018.08.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
4 Mazzeti AL, Capelari-Oliveira P, Bahia MT, Mosqueira VCF. Review on Experimental Treatment Strategies Against Trypanosoma cruzi. J Exp Pharmacol 2021;13:409-32. [PMID: 33833592 DOI: 10.2147/JEP.S267378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ansari MA, Badrealam KF, Alam A, Tufail S, Khalique G, Equbal MJ, Alzohairy MA, Almatroudi A, Alomary MN, Pottoo FH. Recent Nano-based Therapeutic Intervention of Bioactive Sesquiterpenes: Prospects in Cancer Therapeutics. Curr Pharm Des 2020;26:1138-44. [PMID: 31951164 DOI: 10.2174/1381612826666200116151522] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
6 Choudhury SD. Nano-Medicines a Hope for Chagas Disease! Front Mol Biosci 2021;8:655435. [PMID: 34141721 DOI: 10.3389/fmolb.2021.655435] [Reference Citation Analysis]
7 de Castro Leão M, Raffin Pohlmann A, de Cristo Soares Alves A, Helena Poliselli Farsky S, Klimuk Uchiyama M, Araki K, Sandri S, Stanisçuaski Guterres S, Alves Castro I. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. Eur J Pharm Biopharm 2021;159:99-107. [PMID: 33358940 DOI: 10.1016/j.ejpb.2020.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Tupinambá Branquinho R, Pound-Lana G, Marques Milagre M, Saúde-Guimarães DA, Vilela JMC, Spangler Andrade M, de Lana M, Mosqueira VCF. Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation. Sci Rep 2017;7:8429. [PMID: 28814794 DOI: 10.1038/s41598-017-08469-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Branquinho RT, de Mello CGC, Oliveira MT, Reis LES, Vieira PMA, Saúde-Guimarães DA, Mosqueira VCF, de Lana M. Lychnopholide in Poly(d,l-Lactide)-Block-Polyethylene Glycol Nanocapsules Cures Infection with a Drug-Resistant Trypanosoma cruzi Strain at Acute and Chronic Phases. Antimicrob Agents Chemother 2020;64:e01937-19. [PMID: 31988096 DOI: 10.1128/AAC.01937-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Prayag K, Surve DH, Paul AT, Kumar S, Jindal AB. Nanotechnological interventions for treatment of trypanosomiasis in humans and animals. Drug Deliv Transl Res 2020;10:945-61. [PMID: 32383004 DOI: 10.1007/s13346-020-00764-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Souza ACM, Mosqueira VCF, Silveira APA, Antunes LR, Richard S, Guimarães HN, Grabe-Guimarães A. Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice. Parasitology 2018;145:1075-83. [PMID: 29223181 DOI: 10.1017/S0031182017002207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
12 Silva DF, Reis LES, Machado MGC, Dophine DD, de Andrade VR, de Lima WG, Andrade MS, Vilela JMC, Reis AB, Pound-Lana G, Rezende SA, Mosqueira VCF. Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis. Pharmaceutics 2021;13:1061. [PMID: 34371752 DOI: 10.3390/pharmaceutics13071061] [Reference Citation Analysis]
13 Karabasz A, Bzowska M, Szczepanowicz K. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature. Int J Nanomedicine 2020;15:8673-96. [PMID: 33192061 DOI: 10.2147/IJN.S231477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Alphandéry E. Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis. Int J Mol Sci 2022;23:1683. [PMID: 35163604 DOI: 10.3390/ijms23031683] [Reference Citation Analysis]
15 Borges GSM, Lages EB, Sicard P, Ferreira LAM, Richard S. Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies. Front Cardiovasc Med 2021;8:690533. [PMID: 34277738 DOI: 10.3389/fcvm.2021.690533] [Reference Citation Analysis]
16 García M, Aloisio C, Onnainty R, Ullio-gamboa G. Self-assembled nanomaterials. Nanobiomaterials. Elsevier; 2018. pp. 41-94. [DOI: 10.1016/b978-0-08-100716-7.00003-9] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Dichiara M, Marrazzo A, Prezzavento O, Collina S, Rescifina A, Amata E. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases. ChemMedChem 2017;12:1235-53. [PMID: 28590590 DOI: 10.1002/cmdc.201700259] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
18 Garcia GM, Roy J, Pitta IR, Abdalla DSP, Grabe-Guimarães A, Mosqueira VCF, Richard S. Polylactide Nanocapsules Attenuate Adverse Cardiac Cellular Effects of Lyso-7, a Pan-PPAR Agonist/Anti-Inflammatory New Thiazolidinedione. Pharmaceutics 2021;13:1521. [PMID: 34575597 DOI: 10.3390/pharmaceutics13091521] [Reference Citation Analysis]
19 Moreira Souza AC, Grabe-Guimarães A, Cruz JDS, Santos-Miranda A, Farah C, Teixeira Oliveira L, Lucas A, Aimond F, Sicard P, Mosqueira VCF, Richard S. Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation. Br J Pharmacol 2020;177:4448-63. [PMID: 32608017 DOI: 10.1111/bph.15186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Machado MGC, Pound-lana G, de Oliveira MA, Lanna EG, Fialho MCP, de Brito ACF, Barboza APM, Aguiar-soares RDDO, Mosqueira VCF. Labeling PLA-PEG nanocarriers with IR780: physical entrapment versus covalent attachment to polylactide. Drug Deliv and Transl Res 2020;10:1626-43. [DOI: 10.1007/s13346-020-00812-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]